Search
for
Sort by
Research 481–510 of 1000+
- Topische Immuntherapie mit Diphenylcyclopropenon bei verschiedenen Typen der Alpecia areata: Assoziation zu klinischen Parametern und einem funktionellen Genpolymorphismus des Interleukin-6-Promotors
- Patients, Power and Responsibility
- Auswirkungen einer Hormonersatztherapie mit Testosteron auf Haut, Haare und Anhangsgebilde
- An Evaluation System to Enhance Patient Selection for Alopecia-Reducing Surgery
- Comprehensive Program Planning for the Integration of 21st Century Learning Center After-School Programs with Regular Day Programs and Community Partners.
- Festschrift in honor of the 65th birthday of Dr. Howard I. Maibach
- 'The Cry of the Children': The Edwardian Medical Campaign Against Maternal Drinking
- The Impact of Female Pattern Hair Loss on Quality of Life
- Bacterial Diseases of the Skin
- Optimization of polyphenol extraction from Eclipta prostrata L. by response surface methodology
- Oral finasteride use and sexual adverse events: signal detection from disproportionality analyses of data from the United States Food and Drug Administration Adverse Event Reporting System
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- Cetuximab-Associated Elongation of the Eyelashes
- <i>miR‐124</i> promotes neural differentiation in mouse bulge stem cells by repressing <i>Ptbp1</i> and <i>Sox9</i>
- Addressing the average lifespan of skin diseases is critical to good patient care
- RETRACTION: Sonographic Comparison of Subcutaneous Fat Layer Thickness in the Scalp Area in Patients With Androgenetic Alopecia Compared to Healthy Individuals: Cross‐Sectional
- Could baricitinib treat frontal fibrosing alopecia and facial papules?
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
- Side effects of low-dose oral minoxidil for treating alopecia
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System
- Post-marketing safety profile of cladribine in multiple sclerosis: a disproportionality analysis based on the FDA adverse event reporting system
- Drugs linked to blepharitis, meibomian gland dysfunction, and chalazion: a real-world, population-based pharmacovigilance analysis
- Finasteride Use Does Not Lead to Depression or Suicide: Insights From a Large‐Scale Cohort Study and Mendelian Randomization Analysis
- Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
- PD29-07 DRUGS ASSOCIATED THE MOST WITH MALE-FACTOR INFERTILITY: ASSESSMENT OF THE 2010-2020 FOOD AND DRUG ADMINISTRATION (FDA) PHARMACOVIGILANCE DATABASE
- Evaluation of Efficacy of Low-Level Laser Therapy
- Chemotherapy-induced hair loss.